Who Buys Bisoprolol from India — 585 Importers Behind a $84.5M Market

The 585 buyers of Bisoprolol imported from India can be categorized into several segments:

1. Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. (United States, $16.53M) and N.V.O WAREHOUSING & LOGISTICS LTD (Cyprus, $16.36M) function as intermediaries, purchasing large quantities to supply to various healthcare providers. Their order patterns typically involve bulk purchases to ensure a steady supply chain.

2. Contract Manufacturers: Companies such as IPCA LABORATORIES UK LIMITED (United Kingdom, $3.05M) and MEDREICH PLC (United Kingdom, $2.14M) procure Bisoprolol to produce finished pharmaceutical products. Their procurement is aligned with production schedules and client demands, often involving consistent, sizable orders.

3. Re-exporters: Entities like ABCO AIR AND SHIPPING LTD (United Kingdom, $1.84M) purchase Bisoprolol for redistribution to other markets. Their buying behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these segments typically procure Bisoprolol to meet patient needs, with purchasing patterns reflecting prescription rates and inventory management practices.

5. Government Procurement: Organizations such as UNICEF and national health departments often engage in tender-based purchasing to supply public health facilities. Their procurement processes are characterized by large-volume orders and adherence to strict regulatory standards.

For the top five importing countries, the import regulations for Bisoprolol are as follows:

The demand for Bisoprolol in importing countries is driven by several factors:

1. Disease Prevalence: Bisoprolol is primarily used to manage cardiovascular conditions such as hypertension and heart failure. The global rise in non-communicable diseases, particularly cardiovascular diseases, has increased the need for effective treatments.

2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Essential Medicines List, updated in 2025, includes Bisoprolol, encouraging its procurement by member states. (who.int)

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines like Bisoprolol to ensure comprehensive care for populations.

4. Tender-Based Purchasing: Public health facilities often procure medicines through tendering processes to ensure cost-effectiveness and supply chain efficiency.

With 585 buyers across 121 countries, the market for Bisoprolol imported from India demonstrates significant global reach and potential for growth, particularly in regions prioritizing cardiovascular health and access to essential medicines.

The 585 buyers of Bisoprolol imported from India can be categorized into several segments:

1. Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. (United States, $16.53M) and N.V.O WAREHOUSING & LOGISTICS LTD (Cyprus, $16.36M) function as intermediaries, purchasing large quantities to supply to various healthcare providers. Their order patterns typically involve bulk purchases to ensure a steady supply chain.

2. Contract Manufacturers: Companies such as IPCA LABORATORIES UK LIMITED (United Kingdom, $3.05M) and MEDREICH PLC (United Kingdom, $2.14M) procure Bisoprolol to produce finished pharmaceutical products. Their procurement is aligned with production schedules and client demands, often involving consistent, sizable orders.

3. Re-exporters: Entities like ABCO AIR AND SHIPPING LTD (United Kingdom, $1.84M) purchase Bisoprolol for redistribution to other markets. Their buying behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these segments typically procure Bisoprolol to meet patient needs, with purchasing patterns reflecting prescription rates and inventory management practices.

5. Government Procurement: Organizations such as UNICEF and national health departments often engage in tender-based purchasing to supply public health facilities. Their procurement processes are characterized by large-volume orders and adherence to strict regulatory standards.

For the top five importing countries, the import regulations for Bisoprolol are as follows:

The demand for Bisoprolol in importing countries is driven by several factors:

1. Disease Prevalence: Bisoprolol is primarily used to manage cardiovascular conditions such as hypertension and heart failure. The global rise in non-communicable diseases, particularly cardiovascular diseases, has increased the need for effective treatments.

2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Essential Medicines List, updated in 2025, includes Bisoprolol, encouraging its procurement by member states. (who.int)

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines like Bisoprolol to ensure comprehensive care for populations.

4. Tender-Based Purchasing: Public health facilities often procure medicines through tendering processes to ensure cost-effectiveness and supply chain efficiency.

With 585 buyers across 121 countries, the market for Bisoprolol imported from India demonstrates significant global reach and potential for growth, particularly in regions prioritizing cardiovascular health and access to essential medicines.